ProMIS Neurosciences (PMN) said Monday that the US Food and Drug Administration granted Fast Track designation to its lead candidate PMN310 for treating Alzheimer's disease.
Shares more than doubled as intraday trading volume catapulted to over 268.2 million from a daily average of roughly 1.7 million.
ZimVie (ZIMV) said it agreed to be acquired and taken private by healthcare-focused investment firm Archimed for about $730 million.
Shares of ZimVie surged 122% as intraday trading volume climbed to more than 8.9 million from a daily average of about 146,000.
The Ether Machine (ETHM) announced Monday its public launch through a business combination between The Ether Reserve and Dynamix (DYNX).
Shares of Dynamix advanced nearly 16% as intraday trading volume soared to more than 22.2 million from a daily average of about 22,000.
Price: 1.10, Change: +0.66, Percent Change: +149.94